Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System

Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System

Prescription of antipsychotic drugs (APDs) to children has substantially increased in recent years. Whilst current investigations into potential long-term effects have uncovered some alterations to adult behaviours, further investigations into potential changes to neurotransmitter systems are requir...

Full description

Bibliographic Details
Main Authors:	Michael De Santis, Jiamei Lian, Xu-Feng Huang, Chao Deng
Format:	Article
Language:	English
Published:	MDPI AG 2016-11-01
Series:	International Journal of Molecular Sciences
Subjects:	antipsychotic dopamine risperidone olanzapine aripiprazole development juvenile
Online Access:	http://www.mdpi.com/1422-0067/17/11/1944

Similar Items

Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors
by: De Santis M, et al.
Published: (2018-06-01)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
by: Maurizio Pompili, et al.
Published: (2016-10-01)

Metabolic dysregulation in early onset psychiatric disorder before and after exposure to antipsychotic drugs
by: Rehmat Shah, et al.

QSAR–CoMSIA applied to antipsychotic drugs with their dopamine D2 and serotonine 5HT2A membrane receptors
by: SPERANTA AVRAM, et al.
Published: (2011-02-01)

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
by: Tamara Melnik, et al.

Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.
by: Fell, M.J., et al.
Published: (2009)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
by: Maria-Ioanna Stefanou, et al.
Published: (2020-04-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
by: Michael P. Wilson, et al.
Published: (2012-04-01)

Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series
by: Alsayouf HA, et al.
Published: (2020-11-01)

Effects of Haloperidol, Risperidone and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
by: Valentino Racki, et al.
Published: (2021-04-01)

Reversal of risperidone induced galactorrhoea with aripiprazole: a case report
by: Harihar Chilukuri
Published: (2012-01-01)

Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
by: Rehmat Shah, et al.
Published: (2018-11-01)

METHODS ELABORATION ON DETECTION OF SOME ATYPICAL NEUROLYTIC AGENTS FOR CHEMICAL AND TOXICOLOGICAL ANALYSIS
by: I. P. Remezova, et al.
Published: (2015-09-01)

c-Fos expression in the hypothalamic paraventricular nucleus after a single treatment with a typical haloperidol and nine atypical antipsychotics: a pilot study
by: Kiss Alexander
Published: (2018-04-01)

Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study
by: Hamza A. Alsayouf, et al.
Published: (2021-04-01)

Successful treatment of dopamine dysregulation syndrome with dopamine D<sub>2</sub> partial agonist antipsychotic drug
by: Mizushima Jin, et al.
Published: (2012-07-01)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
by: Amir Akhavan Rezayat, et al.
Published: (2014-01-01)

A short term prospective study of the effects of the commonly used antipsychotic drugs on ECG parameters
by: Aditya A Pandurangi, et al.
Published: (2015-01-01)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
by: Pedro Cabral Barata, et al.
Published: (2019-07-01)

Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats
by: László-István Bába, et al.
Published: (2020-10-01)

Report of a Rare Case of Olanzapine and Risperidone Induced Hypomania
by: AR Zahiroddin, et al.
Published: (2006-07-01)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
by: Francisco José Toja-Camba, et al.
Published: (2021-06-01)

Assessment of lipid response to acute olanzapine administration in healthy adults
by: Avital Nahmias, et al.
Published: (2020-04-01)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
by: Eiji Kirino
Published: (2017-11-01)

Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia
by: Javier Labad, et al.
Published: (2020-08-01)

Comparative study of adverse effects of Olanzapine and Risperidone on blood suger, lipid and other side effects in psychotic disorders
by: mitra safa, et al.
Published: (2008-10-01)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
by: Davide Amato, et al.
Published: (2019-05-01)

Effect of aripiprazole and olanzapine on the cognitive function in patients with schizophrenia
by: Xiao-Hong Wang
Published: (2020-05-01)

Amenorrhea associated with olanzapine normalized after switching to aripiprazole: a case report
by: Alpay Ates, et al.
Published: (2012-09-01)

Interruzione del trattamento nei pazienti con schizofrenia che ricevono olanzapina o aripiprazolo: metanalisi degli studi clinici controllati
by: Benedetta Santarlasci, et al.
Published: (2005-03-01)

Risperidone-Induced sexual dysfunction reverted with aripiprazole: Experience from two cases
by: Shreyasee S Bhowmick, et al.
Published: (2020-01-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole
by: Topolov Mariyan K., et al.
Published: (2016-03-01)

The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo
by: Alberto Canfrán-Duque, et al.
Published: (2021-04-01)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
by: Liang Y, et al.
Published: (2017-04-01)

EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01)

Neurobiological Bases of the Use of Atypical Antipsychotics in Treatment-Resistant Major Depressive Disorder
by: Kirby, Julia
Published: (2018)

Sudden Increase of Antipsychotics and Induction of Deep Vein Thrombosis
by: Arghavan Fariborzifar, et al.
Published: (2020-07-01)